1. Home
  2. Banking Profiles

Category: Pharma and Healthcare

Bankers join NHS on the front lines of the fight against Covid-19

Bankers at Barclays, Nomura and Goldman Sachs are among those making masks and joining other efforts during the pandemic

Ill-timed healthcare buyouts bruise KKR and Blackstone

Coronavirus adds to woes at US-based physician-staffing companies Envision and TeamHealth, as some patients stay away from hospitals

ArchiMed invests in US-based health-tech business ActiGraph

Florida-based ActiGraph is the fund’s fifth cross-border investment

AnaCap Financial eyes Nordic expansion for Danish health insurer

Among its main targets are other health insurance companies and their portfolios, healthcare provider networks and health-tech businesses

Dutch private equity firm buys healthcare technology business Corilus

Gilde Buy Out Partners has acquired the company from AAC Capital

Alibaba Health nets $1.3bn from record healthcare follow-on

Alibaba Health Information Technology has sealed Hong Kong’s largest primary follow-on in five years, navigating concerns over high valuations to increase the size of the deal to HK$10bn ($1.29bn).

AMB :- Consonance Capital raises $856m for the second fund

Laxman Pai, Opalesque Asia: New York-based Consonance Capital (CCP) announced that its sophomore private equity fund was closed at its hard cap of $856 million. The healthcare private equity firm said that consistent wi...Article Link

BC Partners hires healthcare specialist from Abu Dhabi’s sovereign wealth fund

Pascal Heberling led Adia's investment in Nestlé Skin Health last year

Blackstone’s Byron Wien weighs in on employment and the healthcare system

Unemployment could reach 20%, Wien said in his monthly market commentary

Health first: venture capital rushes into medical start-ups

In an analysis of US medical venture funding across 17 areas of the human body, the industry set records in both the blood and immune system categories

PE firm buys anti-counterfeit specialist combatting rise in fake drugs amid Covid-19

Brussels-based Advanco provides tracking systems for serialised pharmaceutical products

Fosun-backed Gland Pharma readies Rp65bn IPO

Gland Pharma, a subsidiary of Shanghai Fosun Pharmaceutical Group, has set the final terms for its Rp64.8bn ($866.5m) IPO in India.

RemeGen nets $515m from Hong Kong IPO

Chinese biopharmaceutical firm RemeGen has raised HK$3.99bn ($514.7m) after pricing its IPO at the top of the marketed range, according to a source familiar with the matter.

Alibaba Health launches $1bn share sale

Alibaba Health Information Technology hit the market on Tuesday evening to raise up to HK$8.2bn ($1.06bn) in fresh equity from a follow-on, according to a term sheet seen by GlobalCapital Asia.

Warburg Pincus leads $80m round in NHS data privacy provider Privitar

Other investors include ABN Amro Ventures, Salesforce Ventures, IQ Capital, Partech and Accel

COVID-19 set to shake up private equity performance

Opalesque Industry Update - According to Preqin, 2018/19 vintage funds will see higher returns as a result of the pandemic, while earlier vintages will suffer. The global COVID-19 health crisis has prompted the most extreme

Advent sets up $25m fund to help health workers and portfolio company employees

The Advent Relief Fund will be distributed by the buyout group's local offices

European healthcare specialist closes latest fund at €416m

Gilde Healthcare V will focus on companies that enable improved care at an affordable cost

Socialising and mental health during the Covid-19 crisis

Being isolated from colleagues can lead to workers feeling lonely and lacking motivation

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.